Prenetics Global Ltd
For the period ended Feb 17, 2026. Filed Feb 17, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Feb 17, 2026 · Filed Feb 17, 2026
Use the contents to explore the available documents and sections.
Contents
EXPLANATORY NOTE
Prenetics Global Limited (the “Company”) hereby announces that a member of the Company’s Board of Directors (“Board”), Mr. Kong Yiu (Andy) Cheung, has resigned from his position as director of the Company, effective February 16, 2026.
Mr. Cheung’s decision to step down follows the Company’s strategic shift to focus its resources and management attention entirely on the continued global expansion and scaling of its flagship health and longevity brand, IM8. As part of this renewed focus, the Company has discontinued any future purchases of Bitcoin or other cryptocurrencies, effective December 4, 2025.
The decision did not arise or result from any disagreement between Mr. Cheung and the Company. The Company extends its sincere gratitude to Mr. Cheung for his valuable contributions and leadership during his tenure.
On February 17, 2026, the Company issued a press release announcing the appointment of Dr. Darshan Shah to its Board as an independent director, effective February 16, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Report on Form 6-K (this "Report").
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.